Using the Connectivity Map to discover compounds influencing human osteoblast differentiation

Area of Science:

• Biomedical Science
• Cell Biology
• Pharmacology

Background:

• Osteoporosis is a prevalent skeletal disorder marked by reduced bone mass and increased fracture risk.
• Understanding factors that influence osteoblast differentiation is crucial for developing bone anabolic therapies.
• Previous research identified parbendazole as a compound that stimulates osteogenic differentiation of human mesenchymal stromal cells (hMSCs).

Purpose of the Study:

• To identify novel compounds that modulate osteoblast differentiation using the Connectivity Map (CMap) in-silico approach.
• To validate the efficacy of identified compounds in promoting or inhibiting osteogenic differentiation of hMSCs.
• To identify key genes involved in osteoblast differentiation through gene expression analysis.

Main Methods:

• Gene expression profiling of hMSCs undergoing osteogenic differentiation using Illumina microarrays.
• Utilizing the Connectivity Map (CMap) database to compare osteoblast gene signatures with known compound profiles.
• Experimental validation of identified compounds' effects on hMSC mineralization and dexamethasone-induced osteoblastic differentiation.
• shRNA knockdown of candidate genes (HMOX1, STC1) to assess their role in osteoblast differentiation.

Main Results:

• The CMap approach identified compounds with gene signatures positively correlating with osteoblast differentiation (withaferin-A, calcium folinate, amylocaine) and negatively correlating (salbutamol, metaraminol, diprophylline).
• Positively correlating compounds significantly stimulated osteogenic differentiation and mineralization in hMSCs.
• Withaferin-A and salbutamol showed significant differential expression of HMOX1 and STC1 genes; knockdown of these genes inhibited osteoblast differentiation.
• Salbutamol inhibited dexamethasone-induced osteoblastic differentiation, while metaraminol and diprophylline had no significant effect.

Conclusions:

• The Connectivity Map is an effective tool for discovering compounds that stimulate osteogenesis in hMSCs.
• Withaferin-A and calcium folinate show potential as therapeutic agents for promoting bone formation.
• HMOX1 and STC1 are identified as critical genes in osteoblast differentiation, representing potential therapeutic targets for osteoporosis.